Deep learning for drug repurposing: methods, databases, and applications

A methodological review introduces deep-learning drug-repurposing guidance, covering bioinformatics and pharmacogenomics databases, sequence- and graph-based representations, and COVID-19 applications.

Workflow level n/a Source Preprint (not peer-reviewed) Outcome Not empirically evaluated here

Evidence & verification

Source level

Preprint (not peer-reviewed)
Grounded in a preprint that had not completed peer review at the time the source was checked.

Outcome verification

Not empirically evaluated here
A documented resource or intended workflow, not a demonstrated academic outcome. No empirical benefit is established by its inclusion.

Sources checked

2026-10-17 (UTC)

Abstract-only source review by an AI agent. Abstract supports database and representation coverage and methodological guidance. No claim is made that the editorial team read the underlying studies or verified COVID-19 treatments.

Source-checked does not mean independently reproduced. See the Method page for how these labels are assigned.

Sources (1)

Research applicability

Helps researchers orient methodological choices for AI-assisted drug-repurposing studies. The tutorial-template category denotes introductory methodological guidance, not an executable template.

Getting started

Read the linked arXiv abstract and then the full methods before implementation. Guidance is editorial and untested.

Maintenance

Software maintenance and current distribution not assessed.

License

Licensing and redistribution permissions not audited.

Workflow & human oversight

Automation level unspecified: a resource-level description is not a measured autonomous workflow. Researchers select goals and data and validate outputs.

Workflow level is not an evidence score; higher is not better evidence.

Approach

The abstract outlines database coverage, representation approaches and deep-learning methods, followed by applications and future challenges. It is a review resource, not a newly validated prediction system.

Limitations

Primary arXiv abstract-only review; full text and software not reviewed or executed. The abstract does not expose individual database recommendations, implementation steps or comparative outcomes. The record reports journal acceptance, but publisher full text was not reviewed. Examples do not establish clinical efficacy.

Reproducibility

Fresh arXiv abstract-page retrieval only. No code execution, data reconstruction or independent replication.

Adoption requirements

Editorial, untested guidance: read the full review, then check current database access terms, data suitability and model validation requirements with biomedical specialists. Do not infer a ready-to-run pipeline or clinical recommendation.

Comments

No comments yet.

Add a comment

Comments are held for moderation before appearing. Critical or corrective comments are welcome — especially evidence that an entry overstates what has been verified.